Tie1 attenuation reduces murine atherosclerosis in a dose-dependent and shear stress–specific manner

Although the response of endothelial cells to the disturbed blood flow in the vicinity of atherosclerotic lesions is known to be distinct from that elicited by nonatherogenic laminar flow, the mechanisms involved are poorly understood. Our initial studies confirmed that expression of the endothelial receptor tyrosine kinase Tie1 was evident at regions of atherogenic flow in mature animals. We therefore hypothesized that Tie1 plays a role in the endothelial response to atherogenic shear stress. Consistent with this, we found that Tie1^+/– mice bred to the apoE-deficient background displayed a 35% reduction in atherosclerosis relative to Tie1^+/+;Apoe^–/– mice. Since deletion of Tie1 results in embryonic lethality secondary to vascular dysfunction, we used conditional and inducible mutagenesis to study the effect of endothelial-specific Tie1 attenuation on atherogenesis in Apoe^–/– mice and found a dose-dependent decrease in atherosclerotic lesions. Analysis of primary aortic endothelial cells indicated that atheroprotective laminar flow decreased Tie1 expression in vitro. Attenuation of Tie1 was associated with an increase in eNOS expression and Tie2 phosphorylation. In addition, Tie1 attenuation increased IkBα expression while decreasing ICAM levels. In summary, we have found that shear stress conditions that modulate atherogenic events also regulate Tie1 expression. Therefore, Tie1 may play a novel proinflammatory role in atherosclerosis.

Atherosclerotic lesions have a predilection for locales exposed to disturbed blood flow that can trigger inflammation and apoptosis (1–5). Disturbed flow is seen at the aortic sinus and at branch points such as bifurcations of the carotid, coronary, and renal arteries (2). In contrast, lesions rarely form along nonbranching segments of the descending aorta, where laminar flow is predominant and endothelial cells are protected against inflammatory activation and apoptosis (6, 7), and show increased expression of SOD and eNOS (8).

The force exerted by blood flow on the endothelium is termed shear stress. Mechanosensors of shear stress in endothelial cells include integrins, G protein–coupled receptors, PECAM-1, and the membrane lipid layer (5). The most recent additions to the list of shear stress mediators are the members of the Tie family of receptor tyrosine kinases (9, 10). A tyrosine kinase with immunoglobulin-like and EGF-like domains 1, Tie1 is expressed almost exclusively in endothelial cells (11). Ablation of Tie1 expression results in early embryonic lethality after day 13.5 as a result of severe edema, hemorrhage, and loss of microvessel integrity (12, 13). Puri et al. (12) and Sato et al. (13) have independently shown that Tie1 is not essential for vasculogenesis but is required during embryonic development for the integrity and survival of vascular endothelial cells. Although Tie1 is important for embryonic vessel development, its expression is also increased during pathologic conditions in the adult (14–16). Recent studies have indicated expression of Tie1 in inflammatory tissue of rheumatoid arthritis and osteoarthritis patients (17, 18). Additionally, overexpression of Tie1 augmented the inflammatory markers VCAM-1, ICAM-1, and E-selectin (19). Conversely, analyses of Tie1 siRNA–transfected HUVECs showed a decrease in the levels of inflammatory markers, including TLR2 and IL-1β. These data suggest that Tie1 expression mediates proinflammatory responses in endothelial cells.

Tie1 expression in the adult correlates distinctively to vascular regions exposed to disturbed flow in both physiological and pathological conditions. In optic microvessels, Tie1 promoter activity is increased at bifurcations and downstream of branches (9). The effect of fluid shear on Tie1 has also been demonstrated in vitro, whereby expression is decreased with brief application of laminar flow and altered by acute changes in shear stress magnitude (10). Conversely, disturbed flow in vitro upregulates Tie1 promoter activity (9). Tie1 is commonly found associated with Tie2 (20–22). Overexpression of Tie1 with Tie2 results in a cooperative recruitment of both receptors to the cell border (23). Tie1 can be activated by an Ang1 chimeric protein (COMP-Ang1) as well as by native Ang1 and Ang4, but not by Ang2 or Ang3 (21). Notably, coexpression with Tie2 was required for Tie1 activation (21), and association of Tie1 with Tie2 has been reported to modulate Tie2 activation (22, 24, 25). In bovine aortic endothelial cells subjected to shear stress in vitro (10), Tie1 was cleaved, and the intracellular product was found to coimmunoprecipitate with the protein tyrosine phosphatase Shp2 (26), which indicates that Tie1 might transduce signals in the absence of ligand activation. To our knowledge, the role of Tie1 in shear stress–induced vascular diseases such as atherosclerosis has not previously been studied.

We hypothesized that Tie1 plays an important role in shear stress–induced atherosclerosis and that attenuation of Tie1 would ameliorate atherosclerotic burden. In the present study, we show that Tie1 expression was induced in atherosclerosis-prone regions of the vasculature, characterized by disturbed flow. Moreover, we show that increasing shear stress under laminar flow conditions downregulated Tie1 promoter activity in vivo. We also report a dose-dependent reduction in atherosclerosis in Tie1-attenuated Apoe^–/– mice. Furthermore, we devised what we believe to be a novel method of isolating murine aortic endothelial cells (MAECs), facilitating in vitro experiments in parallel with our in vivo model. In vitro laminar flow with high shear stress for 24 hours downregulated Tie1 levels. Additionally, these in vitro studies document that Tie1 deletion increased shear stress–mediated eNOS and Tie2 phosphorylation, while increasing IkBα and decreasing ICAM levels. Our findings suggest that Tie1 may be a key modulator of endothelial response to pathological shear stress and a novel target of therapy for atherosclerosis.

Tie1 is expressed at regions of atherogenic disturbed flow. Previous studies have shown that Tie1 is ubiquitously expressed in various endothelia at birth, including those of heart, lungs, kidney, liver, and brain (27). To map the expression pattern of Tie1 in adult macrovasculature, we used a transgenic mouse with Tie1 promoter–driven LacZ expression (12). In this model, the LacZ gene is knocked into the Tie1 locus (Tie1^lz/+) and placed under the control of endogenous Tie1 regulatory elements. As expected, Tie1-LacZ activity was ubiquitously expressed throughout the aorta and its branches in 4-week-old animals (Figure 1A), consistent with the role of an activated endothelium. Interestingly, in the 12-week-old adult mouse aorta, this expression was attenuated in the descending aorta (thoracic and abdominal segments). Whereas expression in the thoracic and abdominal aorta was diminished, X-gal staining persisted in the aortic arch and proximal portion of the descending aorta, aortic arch branch arteries, and branches of the descending aorta, including vertebral and renal arteries (Figure 1, B–E). Distinct staining at the outer walls of these vascular bifurcations was observed where conditions of disturbed flow and low shear stress prevail (Figure 1E, inset).

Figure 1

Tie1 expression at shear stress–specific sites in the adult aorta. Representative en face X-gal–stained, whole-mount distal aorta of 4-week-old (A) and 12-week-old (B–E) Tie1-LacZ mice. (A) Pervasive endothelial Tie1-LacZ expression in the aortic arch, branch arteries, and descending aorta wall of immature 4-week-old mouse. (B) Low-magnification view of aorta (aortic arch and thoracic and abdominal aorta) and (C) higher-magnification view depicting endothelial Tie1-LacZ expression in the aortic arch diminishing in the thoracic aorta as laminar flow is restored. (D) High-magnification image of thoracic aorta wall, illustrating endothelial Tie1-LacZ expression at ostia of vertebral artery branches (arrowheads). (E) High-magnification image of abdominal aorta wall, showing distinct X-gal staining at the outer walls of renal artery bifurcations (arrowheads). Inset: illustration of proatherogenic, disturbed flow as experienced at aortic branch points. White arrows indicate direction of blood flow. Original magnification, ×10 (B); ×20 (A and C); ×40 (D and E).

LacZ expression was also detected in the endothelium of the aortic sinus and the aortic valves, areas characterized by disturbed flow (Supplemental Figure 1, A and B; supplemental material available online with this article; doi: 10.1172/JCI42040DS1). We also noted more robust LacZ expression on the fibrosa surface, which experiences disturbed flow compared with the laminar flow of the ventricularis (28, 29). Additionally, X-gal staining was minimal in the ascending aorta, where laminar flow prevails (Supplemental Figure 1G). Since the aortic valve region is prone to atherosclerosis, we studied the effect of hypercholesterolemia caused by Apoe deletion on the endothelial Tie1 expression pattern. In young 4-week-old Tie1^lz/+;Apoe^–/– mice, prior to the appearance of quantifiable atherosclerotic lesions, we noted a similar Tie1-LacZ expression pattern at the aortic sinus (Supplemental Figure 1, C and D) as seen in nonatherosclerotic littermates. This expression pattern persisted in 24-week-old Tie1^lz/+;Apoe^–/– mice with advanced atherosclerotic plaque burden (Supplemental Figure 1, E and F). These results confirmed the persistence of accentuated Tie1 expression in regions characterized by disturbed flow.

In vivo Tie1 expression is reduced by laminar flow with increased shear stress. To study whether shear stress modification in vivo would affect Tie1 expression, we used shear stress–modifying casts (Figure 2, A and B). We implanted casts around the right common carotid artery of Tie1-LacZ mice for 7 days. These casts modulate endogenous shear stress by inducing lowered shear stress immediately upstream, increased shear stress inside the cast, and oscillatory shear stress with vortex flow immediately downstream (30, 31). Cheng et al. previously described increased eNOS activity in the tapered region of the cast, where laminar flow with increased shear stress is found (30), and documented formation of atherosclerotic lesions in the adjacent upstream region experiencing laminar flow with low shear stress and in the immediate downstream area undergoing oscillatory flow (31). Right common carotid arteries implanted with control nontapered casts (n = 4) expressed LacZ uniformly along the vessel (Figure 2D), similar to nonimplanted left subclavian and left carotid arteries. In contrast, X-gal staining was attenuated in the tapered region of the cast, where laminar flow with increased shear stress is induced (n = 4; Figure 2C). Comparable to controls, LacZ activity persisted in the aforementioned regions adjacent to the cast. Persistent endothelial expression of VE-cadherin in the areas of increased shear stress confirmed that the attenuation of Tie1-LacZ activity was not the result of endothelial denudation (Supplemental Figure 2), as also previously documented by others (29, 31). These results suggest that Tie1 expression is attenuated by conditions of increased endogenous shear stress with laminar flow. Furthermore, these results are suggestive of dynamic repression of Tie1 promoter activity in the short term (7 days).

Figure 2

Tie1 promoter activity is downregulated by laminar flow with increased shear stress. (A) Tapered and nontapered control casts that were surgically implanted in mouse carotid arteries. Scale bar: 1 mm. (B) Illustration of tapered casts manipulating in vivo shear stress, inducing lowered shear stress upstream, increased shear stress inside, and oscillatory flow with shear stress immediately downstream of the cast. Control nontapered casts do not interfere with in vivo shear stress. (C and D) Representative whole-mount X-gal–stained Tie1-LacZ mouse carotid arteries with shear stress–modifying casts 7 days after implantation. (C) Tapered cast showed diminished X-gal staining along the region of increased shear stress inside the cast. (D) Control nontapered casts demonstrated persistent uniform X-gal staining. RCCA, right common carotid artery; LCA, left carotid artery; Ao arch, aortic arch. Original magnification, ×50.

Tie1 suppression reduces distal aorta atherosclerosis progression in Apoe-null mice. To determine the role of Tie1 in atherosclerosis, Tie1^+/–;Apoe^–/– female mice (n = 49) fed a regular chow diet were evaluated for atherosclerotic plaque burden and compared with control Tie1^+/+;Apoe^–/– female littermates (n = 41). Female mice were chosen because of a clear gender-dependent difference in the progression of atherosclerosis (32). Mice were assessed at early (12 weeks old), intermediate (18 weeks old), and advanced (24 and 49 weeks old) stages of atherosclerosis. There were no statistically significant differences in serum cholesterol and triglyceride levels between experimental and control mice (Table 1). Semiquantitative RT-PCR analysis of descending aorta confirmed a 49% decrease in Tie1 mRNA expression of Tie1^+/– mice (Figure 3A). Western blot assay of pulmonary endothelia showed a 40% reduction in Tie1 protein expression throughout the vascular endothelium (Figure 3B).

Figure 3

Tie1 heterozygosity reduces advanced-stage atherosclerosis burden. (A and B) Quantitation of Tie1 levels in Tie1^+/– mice of (A) aortic endothelia by RT-PCR (49% reduction, P < 0.01, n = 4) and (B) pulmonary tissue by Western blot (40% suppression, P < 0.05). (C and D) Effect of reduced Tie1 expression on atherosclerosis. (C) Representative images of Sudan IV–stained aorta (aortic arch and thoracic and abdominal aorta) from 49-week-old Tie1^+/+;Apoe^–/– and Tie1^+/–;Apoe^–/– mice. (D) Atherosclerotic lesion area in Tie1^+/+;Apoe^–/– versus Tie1^+/–;Apoe^–/– mice at 12, 18, 24, and 49 weeks of age. Data points denote individual animals; horizontal bars indicate group average. *P < 0.05; **P < 0.01.

Table 1

Plasma cholesterol and triglyceride levels for Apoe^–/– mice

In the atherosclerosis-prone, disturbed-flow regions of the aorta, en face analysis showed 37.9% suppression of atherosclerotic lesions in 24-week-old mice (Tie1^+/+;Apoe^–/–, 1.69% ± 0.24%; Tie1^+/–;Apoe^–/–, 1.04% ± 0.20%, P < 0.05; Figure 3D). This difference persisted for 6 months (i.e., 49 weeks of age), when the area covered by lesions was 16.13% ± 2.80% in Tie1^+/+;Apoe^–/– and 10.57% ± 1.49% in Tie1^+/–;Apoe^–/– mice (34.4% reduction, P < 0.05; Figure 3, C and D). Interestingly, no statistically significant differences were found in the early and intermediate disease stage groups, although trends were confirmatory of what was seen at later disease stages (12 weeks, 0.61% ± 0.14% vs. 0.49% ± 0.05%, P = NS; 18 weeks, 1.52% ± 0.84% vs. 0.55% ± 0.05%, P = NS; Figure 3D).

In the aortic sinus, we found no statistically significant differences in the extent of lesion area between Tie1^+/+;Apoe^–/– and Tie1^+/–;Apoe^–/– mice at any stage (12 weeks, 40,030 ± 15,311 vs. 51,719 ± 6,094 μm²; 18 weeks, 156,155 ± 40,275 vs. 152,210 ± 25,157 μm²; 24 weeks, 286,433 ± 16,160 vs. 334,760 ± 41,861 μm²; 49 weeks, 426,680 ± 40,877 vs. 529,025 ± 52,711 μm²; Supplemental Figure 3A). The trend toward increased lesions in Tie1^+/–;Apoe^–/– mice, the opposite of the effects seen in the distal aorta, is interesting but does not warrant further comment, given the lack of statistical significance.

Endothelial-specific Tie1 deficiency alleviates atherosclerosis progression in a dose-dependent manner. We next assessed the effect of endothelial-specific Tie1 deletion on development of atherosclerotic lesions in Apoe^–/– mice. Since Tie1 deletion leads to early embryonic lethality (12, 13), we used Cre-Lox technology to delete Tie1 in a spatially and temporally defined manner. We used SCL-ER^T-Cre mice to achieve endothelial-specific, tamoxifen-mediated induction of Cre expression (33). To determine an efficient tamoxifen induction dosage, SCL-ER^T-Cre mice were bred to Rosa-LacZ reporter background. Using a protocol of 2 mg intraperitoneal tamoxifen injection every 48 hours, for 14 days, we were able to obtain robust, endothelial-specific, Cre-mediated deletion (evidenced by X-gal staining), as documented in the aortic valve endothelium and in the microvasculature of the endocardium (Figure 4A). Tie1^–/fl mice were then bred with SCL-ER^T-Cre mice, and generalized endothelial-specific deletion was quantified by Western assay of pulmonary endothelium, which showed a 81% reduction in Tie1 protein levels (Supplemental Figure 4). In the resulting mice with a null Tie1 allele, a floxed Tie1 allele, and endothelial-specific Cre (Tie1^–/fl;SCL-ER^T-Cre mice), tamoxifen treatment induced a 65% reduction in aortic endothelial Tie1 mRNA level (Figure 4B).

Figure 4

Endothelial-specific Tie1 deletion reduces atherosclerosis burden. (A) Representative H&E-stained aortic valve showing endothelial-specific LacZ expression (arrowheads) from tamoxifen-treated SCL-ER^T-Cre;Rosa26R-LacZ mouse. Original magnification, ×100. (B) RT-PCR analysis of aortic Tie1 levels from tamoxifen-treated Tie1^–/fl;SCL-ER^T-Cre mice (65% reduction, P < 0.05). (C) Representative Sudan IV–stained distal aorta from Tie1^–/fl;SCL-ER^T-Cre;Apoe^–/– and Tie1^fl/fl;Apoe^–/– mice demonstrated lesion reductions in Tie1-deleted mice. (D and E) Mean aortic lesion area in tamoxifen-treated Tie1^–/fl;SCL-ER^T-Cre;Apoe^–/– and Tie1^fl/fl;Apoe^–/– mice analyzed at (D) 12 weeks (68% reduction, P < 0.0005) and (E) 24 weeks (70% reduction, P < 0.006). (F–H) Atherosclerotic lesion areas in Tie1-deleted mice, as assessed in 3 regions of the aorta, showed reduction of atherosclerosis in all regions of disturbed flow. Insets show respective regions of lesion analysis. Shown are mean atherosclerotic lesion areas at (F) lesser curvature of the aortic arch (12 weeks, 0.066% ± 0.023% vs. 0.038% ± 0.014%, P = NS; 24 weeks, 1.20% ± 0.379% vs. 0.206% ± 0.048%, 82% reduction, P < 0.01); (G) aortic arch branch arteries, including brachiocephalic, left common carotid, and left subclavian arteries (12 weeks, 0.211% ± 0.055% vs. 0.086% ± 0.026%, 56% reduction, P < 0.05; 24 weeks, 1.29% ± 0.283% vs. 0.568% ± 0.119%, 59% reduction, P < 0.05); and (H) descending aorta (12 weeks, 0.487% ± 0.074% vs. 0.118% ± 0.032%, 70% reduction, P < 0.01; 24 weeks, 1.13% ± 0.291% vs. 0.333% ± 0.097%, 75% reduction, P < 0.01). Data points denote individual animals, and horizontal bars indicate group average. *P < 0.05; **P < 0.01; ***P < 0.001.

To assess the effect of Tie1 deletion on atherosclerosis progression, Tie1^–/fl;SCL-ER^T-Cre mice were bred onto the Apoe^–/– background. Tie1^–/fl;SCL-ER^T-Cre;Apoe^–/– female mice and control Tie1^fl/fl;Apoe^–/– female littermates were injected with tamoxifen as described above. Because tamoxifen administration has previously been associated with attenuation of atherosclerosis after chronic and unfettered oral intake (34), we first determined whether acute and limited exposure to tamoxifen had any effect in our experimental model. We noted a protective effect (46% decrease) 4 weeks after treatment (i.e., 12 weeks old; 1.41% ± 0.22% vs. 0.76% ± 0.11%, P < 0.01; Supplemental Figure 5), which was not maintained at the 16-week time point (i.e., 24 weeks old; 4.32% ± 0.54% vs. 3.64% ± 0.86%, P = NS). Tamoxifen treatment temporarily decreased serum cholesterol in Tie1^fl/fl;Apoe^–/– mice compared with untreated controls at 12 weeks of age (456.44 ± 40.58 vs. 291.43 ± 19.36 mg/dl, P < 0.001), but this effect was lost by 24 weeks (331.54 ± 28.54 vs. 345.20 ± 24.61 mg/dl, P = NS; Table 2). Tamoxifen treatment also reduced serum triglycerides of 12- and 24-week-old animals (12 weeks old, 186.8 ± 8.00 vs. 147.98 ± 7.38 mg/dl, P < 0.01; 24 weeks old, 200.64 ± 9.81 vs. 141.95 ± 9.44 mg/dl, P < 0.01; Table 2). However, the tamoxifen-induced reduction in serum triglycerides was not associated with an atheroprotective effect at 24 weeks.

Table 2

Plasma cholesterol and triglycerides for tamoxifen-treated Apoe^–/– mice

Consistent with our previous studies, en face analysis of the aorta from Tie1-deleted animals showed a statistically significant reduction in atherosclerotic lesions. In 12-week-old mice with early disease progression, we found a 68% decrease in lesions of Tie1-deleted mice compared with controls (0.765% ± 0.114% vs. 0.244% ± 0.046%, P < 0.0005; Figure 4D). The decrease in atherosclerosis persisted in mice up to 24 weeks of age, when Tie1 deletion resulted in a 70% decrease in plaque progression compared with controls (3.644% ± 0.865% vs. 1.108% ± 0.207%, P < 0.006; Figure 4, C and E). However, similar to the atherosclerosis data in Tie1-heterozygous mice, we observed no significant difference in the degree of atherosclerosis at the aortic sinus between control Tie1^fl/fl;Apoe^–/– and Tie1^–/flox;SCL-ER^T-Cre;Apoe^–/– mice (12 weeks old, 16,607 ± 5,004 vs. 21,126 ± 4,274 μm²; 24 weeks old, 22,816 ± 3,019 vs. 18,587 ± 33,856 μm²; Supplemental Figure 3B).

Tie1 deletion had no effect on serum cholesterol levels compared with controls when both groups were treated with tamoxifen (Table 2). Serum triglycerides in Tie1-deleted mice treated with tamoxifen were slightly increased compared with tamoxifen-treated controls, but similar to those of untreated controls (172.9, 147.9, and 186.8 mg/dl, respectively; Table 2). These results suggest that deletion of endothelial Tie1 has a protective effect attenuating the rate of atherosclerosis progression independent of effects on serum cholesterol or triglyceride levels.

Reduction of atherosclerosis caused by Tie1 deletion may be location specific. To determine whether Tie1 deletion has an effect on atherosclerosis distribution based on location and type of shear stress, we analyzed lesions at (a) bifurcations of the aortic arch branch arteries, (b) the lesser curvature of the aortic arch, and (c) the descending thoracic and abdominal aorta. Lesion sizes at all locations were decreased as a consequence of Tie1 deletion (Figure 4, F–H), which suggests that Tie1 plays a role in disturbed flow–mediated atherogenesis at each of these locations.

Tie1 is not expressed in macrophages, and Tie1 reduction in vivo reduces macrophage infiltration. As shown by macrophage immunostaining, we found a 56% reduction of macrophage infiltration in Tie1^+/–;Apoe^–/– compared with control Tie1^+/+;Apoe^–/– mice (0.33 ± 0.03 vs. 0.07 ± 0.44 U, n = 3, P < 0.01; Supplemental Figure 6A), consistent with a decrease in inflammation associated with the attenuation in atherosclerosis. Similarly, analyses of tamoxifen-treated Tie1^–/fl;SCL-ER^T-Cre;Apoe^–/– and Tie1^fl/fl;Apoe^–/– control animals revealed a 70% reduction in macrophage infiltration (0.46 ± 0.07 vs. 0.14 ± 0.03 U, n = 3, P < 0.05; Supplemental Figure 6B). To determine whether Tie1 deletion within macrophage populations contributes to the attenuation in atherosclerosis, we evaluated the expression of Tie1 in primary macrophages. RT-PCR analysis demonstrated that there was no detectable Tie1 mRNA in macrophages (Supplemental Figure 6C); thus, a cell-autonomous effect of Tie1 in the macrophage population is unlikely to contribute to the decreased inflammation observed.

Tie1 attenuation in vivo reduces expression of Rho-associated, coiled-coil containing protein kinases (ROCK1 and ROCK2) and cell adhesion molecules and increases eNOS levels. To elucidate the effect of Tie1 deletion on inflammatory biomarker expression in vivo, we assayed RNA from the descending thoracic and abdominal aorta of tamoxifen-treated Tie1^–/fl;SCL-ER^T-Cre mice and control Tie1^fl/fl mice. mRNA levels of ROCK1 and ROCK2 were attenuated by 70% and 52%, respectively, whereas eNOS mRNA was increased (Figure 5, B–D). ICAM and VCAM mRNA expression were also decreased by 55% and 87%, respectively (Figure 5, E and F).

Figure 5

In vivo deletion of Tie1 promotes antiinflammatory effect. Analyses of descending aorta mRNA from tamoxifen-treated Tie1^fl/fl and Tie1^–/fl;SCL-ER^T-Cre mice. Semiquantitative RT-PCR assay of (A) Tie1 (P < 0.0001), (B) eNOS (P < 0.01), (C) ROCK1 (P < 0.001), (D) ROCK2 (P < 0.002), (E) ICAM (P < 0.05), and (F) VCAM (P < 0.001). n = 3 per group. *P < 0.05.

Tie1 deletion in vitro augments shear stress–induced eNOS expression and reduces proinflammatory signaling. To determine the effect of Tie1 deletion on endothelial cell response to altered shear stress in vitro, we developed an immortalized MAEC line from both wild-type and Tie1^fl/fl;SCL-ER^T-Cre mice. Conditionally immortalized cells were derived from the H-2K^b–tsA58 transgenic mouse. Expression of the inducible tsA58 tumor Ag (TAg) allows for the extended propagation of MAECs under permissive conditions. At passage 10, fluorescence-activated cell sorting analysis showed 89.7% positive immunostaining for CD31 (Supplemental Figure 7A). PECAM immunostaining showed uniform cytoplasmic distribution and increased localization to the cell border in apposition with adjacent cells (Supplemental Figure 7B). We also documented that MAECs took up 1,1′-dioctadecyl-3,3,3′3′-tetramethylindocarbocyanine perchlorate–labeled acetylated LDL (DiI-AcLDL; Supplemental Figure 7C) and showed robust network formation within 24 hours in Matrigel (Supplemental Figure 7D). Our MAECs displayed cobblestone morphology (Supplemental Figure 7E) and aligned to the direction of laminar flow with high shear stress after 24 hours (Supplemental Figure 7F). These results demonstrated that MAECs isolated from immorto mice display the same characteristics of many primary endothelial cell lines.

Next, we isolated endothelial cells from homozygous Tie1^fl/fl;SCL-ER^T-Cre immorto mice, allowing for the use of 4-hydroxytamoxifen (4OHT), the active metabolite of tamoxifen, to initiate Cre transcription and hence induce Tie1 deletion. To ascertain activation of Cre in vitro, we immunostained 4OHT-treated Tie1^fl/fl;SCL-ER^T-Cre MAECs using Cre antibody. Increased nuclear staining indicates successful translocation of Cre (Figure 6, A and B). RT-PCR and Western blot analyses of full-length Tie1 indicate 4OHT administration resulted in 41% and 45% reductions, respectively, of Tie1 expression (Figure 6, C and D). Additionally, the cleaved Tie1 intracellular fragment (26, 35, 36) was reduced by 72% (Figure 6E).

Figure 6

In vitro deletion of Tie1 and endothelial cell response to shear stress. (A–E) Treatment of Tie1^fl/fl;SCL-ER^T-Cre MAECs with 4OHT activated Cre and reduced Tie1 expression. Representative immunofluorescent images showing Cre nuclear localization following 4OHT treatment (B) compared with untreated controls (A). Scale bars: 100 μm. (C) RT-PCR analysis of Tie1 mRNA levels. Western blot analyses of full-length protein levels (D) and cleaved Tie1 (Cl Tie1) 45-kDa endodomain levels (E). (F) Western blot analysis of full-length Tie1 receptor after 24 hours of shear stress showed that laminar flow at 20 dynes/cm² (Lss20) decreased Tie1 expression. (G–K) Western blot analyses of Tie1-deleted (i.e., 4OHT-treated) versus untreated control cells, comparing laminar shear–induced eNOS expression (G), eNOS phosphorylation (H), ICAM expression (I), IkBα expression (J), and Tie2 phosphorylation (normalized to Tie2) (K). *P < 0.05.

We then exposed our MAECs to high–shear stress laminar flow for 24 hours. In our MAECs, laminar flow at 20 dynes/cm² decreased Tie1 receptor expression by approximately 40% (Figure 6F), and oscillatory flow at 5 dynes/cm² increased Tie1 expression by 30% (Supplemental Figure 8). Laminar flow also increased eNOS protein levels and potentiated eNOS phosphorylation in Tie1^fl/fl;SCL-ER^T-Cre MAECs, as expected (37). Interestingly, eNOS expression and phosphorylation were further augmented by laminar flow after tamoxifen-induced deletion of Tie1 (Figure 6, G and H). In addition, Tie1 deletion further decreased shear stress–induced ICAM expression and increased IkBα expression in response to laminar shear (Figure 6, I and J). We next observed that laminar flow increased Tie2 phosphorylation (38), and this shear stress–mediated increase in phosphorylation was accentuated by deletion of Tie1 (Figure 6K). Moreover, in vitro oscillatory flow resulted in an increase in Tie1 expression (Supplemental Figure 8A), and attenuation of Tie1 under similar flow conditions increased eNOS expression and decreased p50 nuclear translocation (Supplemental Figure 8, B and C). In conclusion, these results suggest that Tie1 expression is regulated by shear stress and that Tie1 may have a proinflammatory role in promoting the progression of atherosclerosis.

Our present findings provide major insights into the role of Tie1 in atherosclerosis. First, Tie1 expression was accentuated in regions of atherogenic shear stress, such as those with disturbed flow in the adult aorta. Second, there was dynamic downregulation of Tie1 expression in vitro and in vivo under conditions of laminar flow with high shear stress. Third, in conjunction with the expression of Tie1 at atherosclerosis-prone areas, we found that Tie1 reduction alleviated atherosclerosis progression in a dose-dependent manner. Finally, our in vitro and in vivo data support a proinflammatory role for Tie1.

Previous in vivo studies have focused on the role of Tie1 in early stages of embryonic development. Here, we showed that the expression pattern of Tie1 in the adult macrovasculature was different from that of the immature mouse. In the aorta of a young 4-week-old mouse, we observed pervasive endothelial Tie1 expression consistent with aortic immaturity. However, in the 12-week-old adult mouse, Tie1 expression decreased specifically in the descending aorta. We noted strong X-gal staining at locales subjected to atherogenic disturbed flow (39), such as the aortic arch and its branch vessels, and bifurcations of the vertebral and renal arteries. LacZ expression was also observed at the aortic sinus and the aortic valves, areas characterized by disturbed flow.

The effect of altered shear stress on Tie1 expression was demonstrated in vivo by the use of vascular casts. Cheng et al. previously demonstrated that these in vivo shear stress–modifying casts altered the shear forces in the carotid arteries of Apoe-null mice (31). Lowered shear stress upstream of the cast was found to induce formation of unstable plaques, and the immediate downstream region of the cast formed stable plaques in the presence of oscillatory flow. In our Tie1-LacZ reporter mice, we found persistence of Tie1 promoter–driven LacZ expression also in these immediate vicinities around the cast. Furthermore, Cheng and colleagues reported increased eNOS expression and detected no atherosclerotic lesions within the boundaries of the tapered cast (30). Interestingly, we found a dramatic reduction in Tie1 promoter activity after only 7 days of implanting tapered casts in Tie1-LacZ mice. Attenuation of LacZ expression was distinctly confined to the boundaries of the tapered cast, where shear stress increases from 10 to 25 N/m². Hence, the attenuation of Tie1 expression may be caused, at least in part, by both the higher shear stress magnitude and laminar flow conditions.

Interestingly, the in vivo response of endothelial cells to the same magnitude of shear stress may be context dependent, with endothelial cells from different vascular beds having different set points for response to shear stress. There is significant variability in the absolute wall shear stress of vascular regions within a given species, as well as between similar regions in the same species (reviewed in ref. 40). The shear stress of the mouse abdominal aorta is approximately 9 N/m² (41), and in our studies, little Tie1 expression was detected in the regions of laminar shear, but Tie1 expression persisted in regions of nonlaminar flow. By comparison, the average shear stress of the carotid arteries in mice has been calculated to be 15 N/m² (31), and Tie1 was expressed in carotid endothelial cells under normal conditions. However, when shear stress in the carotid arteries was increased by placement of vascular casts to 25 N/m², a magnitude comparable to the level of shear stress produced in most in vitro studies, there was a marked attenuation in Tie1 expression. Clearly, shear stress is not the only factor regulating Tie1 expression, but our data suggest that expression of Tie1 is downregulated in vitro and in vivo by shear stress profiles that are thought to be atheroprotective.

Since we found expression of Tie1 at regions of atherogenic shear stress, and a previous study reported Tie1 expression on both the surface and the subendothelium of atherosclerotic lesions (9), we postulated that attenuation of Tie1 may modulate atherosclerosis progression. We found that moderate reductions in Tie1 (Tie1^+/–;Apoe^–/– mice) elicited 35% and 38% reductions in atherosclerotic lesions of 24- and 49-week-old mice, respectively. Remarkably, further reductions of Tie1 by up to 80% in Tie1^–/fl;SCL-ER^T-Cre;Apoe^–/– mice resulted in 68% and 70% reduction in lesions of 12- and 24-week-old mice, respectively. Hence, using 2 different mouse models, our results demonstrated that Tie1 attenuation conferred amelioration of atherosclerosis progression.

To our knowledge, this is the first report of an in vivo biological function for Tie1 in the adult mouse. Whereas Tie1 plays a requisite role in prenatal vascular integrity (12, 42), our results suggest that loss of Tie1 in late adult stages confers an atheroprotective effect. This divergence in function may be due in part to the complex shear stress magnitudes and flow profiles experienced pre- and postnatally. Kontos et al. previously showed that Tie1 is capable of activating Akt to promote cell survival (43); Tie1 is also required for the maintenance of various adult vascular endothelial cell populations (12). Hence, Tie receptors may possess context-dependent roles (44) that are not only defined by endothelial heterogeneity, but also influenced by the physiologic environment that changes during vascular maturity.

We also noted that attenuation of Tie1 did not significantly alter the extent of atherosclerotic lesions, as assessed by quantification of lipid accumulation in the aortic valve region. However, there was a clear decrease in macrophage infiltration in this region. Interestingly, Tie1 attenuation elicited a trend of increased lesions at the aortic sinus, an effect opposite to that observed in the distal aorta. Previous studies have demonstrated a predilection of lesions for specific locales of the distal aorta in PECAM-knockout mice on either the Apoe-deficient or the LDL receptor–deficient background (45, 46). The aortic valve also experiences a unique and complex shear stress profile not evidenced elsewhere in the vasculature. Peacock previously described the flow profile in the aortic sinus as turbulent, composed of spinning vortices superimposed with random motion of fluid particles (28). In contrast, the flow profile at aortic bifurcations distal to the aortic sinus has been described as recirculatory (4), characterized by bidirectional blood flow with the resultant effect of a low time-averaged shear stress (2). Additionally, Butcher et al. demonstrated that the shear stress–induced transcriptional response of valvular endothelial cells is vastly different from aortic endothelial cells. More than 400 genes were differentially expressed, and overall, the inflammatory response of valvular endothelial cells were found to be less pronounced than that of aortic endothelial cells (47). Hence, Tie1 may regulate atherosclerosis progression in a shear stress–specific manner, discriminating between different flow profiles characteristic of unique anatomical and physiological locations within the vascular system and further highlighting the context-dependent response of heterogeneous endothelial populations.

To further investigate the effect of shear stress on Tie1 expression in vitro, we devised a method of isolating genetically modified MAECs that maintain a high percentage of cells displaying endothelial characteristics. The culture of MAECs is a technically challenging process, often resulting in low yields with poor propagation properties. We circumnavigated these problems through the generation of conditionally immortalized aortic endothelial cells from Tie1^fl/fl;SCL-ER^T-Cre immorto mice and selecting with PECAM by flow-assisted cell sorting. Jat et al. first reported the derivation of conditionally immortalized cell lines from the H-2K^b–tsA58 transgenic mouse (48); subsequently, several groups have successfully isolated a variety of cell lines from this mouse (49–51). In this model, the large TAg of a temperature-sensitive strain (tsA58) of the simian virus 40 (SV40) is fused with the major histocompatibility complex promoter H-2K^b, which is active in a wide range of tissues and is induced by IFNs. The presence of the inducible tsA58 TAg allows for the extended propagation of MAECs under permissive conditions (33°C, IFN-γ). MAECs transferred to normal culture conditions (37°C) were confirmed to be endothelial by their characteristic cobblestone morphology, formation of microtubules on Matrigel, expression of CD31, and uptake of DiI-AcLDL. Additionally, MAECs aligned to the direction of laminar flow after only 24 hours (52). Our results indicate that immortalized MAECs display the characteristics germane to many primary endothelial cell lines.

We achieved 50% deletion of Tie1 in vitro, concordant with in vivo tamoxifen-induced deletion in Tie1^fl/fl;SCL-ER^T-Cre mice. We surmise that Cre expression under the SCL promoter may not be sufficient for extensive deletion of biallelic floxed Tie1 and anticipate that enhanced deletion could be achieved by development of Tie1^–/fl;SCL-ER^T-Cre cells. Marron et al. previously reported cleavage of Tie1 with phorbol ester or VEGF (35), while Chen-Konak and colleagues reported changes in levels of Tie1 intracellular fragment after brief alterations in shear stress (10). Upon administration of 4OHT, we also noted a concomitant decrease in levels of cleaved Tie1 intracellular fragment. Whereas deletion of Tie1 resulted in a 50% reduction in full-length Tie1 receptor, the cleaved Tie1 fragment was decreased by 74%. The significance of this observation is currently being explored.

Our in vitro experiments in MAECs showed that 24 hours of laminar flow at 20 dynes/cm² suppressed Tie1 expression and increased eNOS activity, while oscillatory flow at 5 dynes/cm² for a similar duration augmented expression of Tie1. Using bovine aortic endothelial cells, Chen-Konak et al. found that brief in vitro application of shear stress at 10 dynes/cm² temporarily decreased Tie1, but expression levels returned to baseline after 2 hours (10). Therefore, our in vitro model recapitulated our in vivo data showing increased Tie1 expression at regions of disturbed flow. Stability of eNOS may be regulated by ROCK1 and ROCK2 (53, 54). We showed that genetic deletion of Tie1 augmented eNOS activity in vivo and in vitro while downregulating the transcription of ROCK1 and ROCK2 in vivo. Hence, our data suggest that Tie1 may signal upstream of the ROCK-eNOS signaling pathway.

An octameric negative shear stress response element that downregulates Tie1 expression has also been found (10). Shear stress response elements are targets of the NF-κB transcription factor, which in turn can also be regulated by shear stress (55). Recent studies have shown that siRNA silencing of Tie1 in vitro reduced expression of inflammatory markers (56), and overexpression studies demonstrated complementary findings (19), suggestive of a proinflammatory role for Tie1. We found that Tie1 deletion augmented shear stress–induced IkBα expression in vitro while decreasing expression of inflammatory biomarkers both in vivo and in vitro.

Finally, the effect of Tie1 deletion on the progression of atherosclerosis is unlikely to be exclusively related to decreases in Tie1-mediated signaling. As mentioned above, Tie1 and Tie2 have been shown to interact physically (21, 23, 24), but the in vivo biological relevance of these interactions has not been demonstrated. Attenuation of Tie1 has been shown to upregulate Tie2 phosphorylation (22), as has laminar flow (38). Our results showed that the combination of shear stress and Tie1 deletion augmented the increased phosphorylation of Tie2. Interestingly, increased Tie2 signaling has recently been associated with a decrease in atherosclerosis (57). A recent fluorescent resonance energy transfer–based proximity assay has documented Tie1-Tie2 complex formation at the cell surface and demonstrated that these interactions are inhibitory for Tie2 signaling (25). We did not observe a difference in the expression of either Ang1 or Ang2 in response to Tie1 attenuation following 24 hours of in vitro laminar flow (data not shown). Therefore, it is likely that the increased phosphorylation of Tie2 under these conditions (Figure 6K) may be explained, at least in part, by the relief of inhibitory interactions normally imposed by association with Tie1.

In summary, we found that Tie1 was expressed in specific regions experiencing atherogenic shear stress, and reduction of Tie1 expression attenuated atherosclerosis progression in a shear stress–specific and dose-dependent manner. Our in vitro shear stress studies further suggest a proinflammatory role for Tie1, which we believe to be novel. This prophylactic alleviation of atherosclerosis burden by the reduction of Tie1 expression and signaling points to Tie1 as an attractive candidate for targeted therapeutic approaches.

View Supplemental data

We thank Youmin Zhang for excellent technical expertise. We also thank Christopher Brown for invaluable support and experimental advice. K.V. Woo was supported by the Vanderbilt Medical Scientist Training Program (NIH grant T32 GM007347-31) and an American Heart Association Predoctoral Fellowship. H.S. Baldwin and K.V. Woo were supported by NIH grants RL1 HL0952551 and MOD FY07-513 (both to H.S. Baldwin). S. Fazio was supported by NIH R01 grants 65709 and 57986. M.F. Linton was supported by NIH grants HL065405 and HL086988. This work was also supported by NIH grant DK59637 (Lipid, Lipoprotein, and Atherosclerosis Core of the Vanderbilt Mouse Metabolic Phenotype Centers).

Address correspondence to: H. Scott Baldwin, 9435-A MRB IV, Vanderbilt University Medical Center, Nashville, Tennessee 37232- 0493, USA. Phone: 615.322.2703; Fax: 615.322.6541; E-mail: scott.baldwin@vanderbilt.edu.

Conflict of interest: The authors have declared that no conflict of interest exists.

Reference information: J Clin Invest. 2011;121(4):1624–1635. doi:10.1172/JCI42040.

1. Cornhill JF, Roach MR. A quantitative study of the localization of atherosclerotic lesions in the rabbit aorta. Atherosclerosis. 1976;23(3):489–501.
   View this article via: PubMed CrossRef Google Scholar
2. Davies PF, Polacek DC, Handen JS, Helmke BP, DePaola N. A spatial approach to transcriptional profiling: mechanotransduction and the focal origin of atherosclerosis. Trends Biotechnol. 1999;17(9):347–351.
   View this article via: PubMed CrossRef Google Scholar
3. Gimbrone MA Jr, Nagel T, Topper JN. Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J Clin Invest. 1997;100(11 suppl):S61–S65.
   View this article via: JCI PubMed Google Scholar
4. Asakura T, Karino T. Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries. Circ Res. 1990;66(4):1045–1066.
   View this article via: PubMed Google Scholar
5. Li YS, Haga JH, Chien S. Molecular basis of the effects of shear stress on vascular endothelial cells. J Biomech. 2005;38(10):1949–1971.
   View this article via: PubMed CrossRef Google Scholar
6. Chien S. Role of shear stress direction in endothelial mechanotransduction. Mol Cell Biomech. 2008;5(1):1–8.
   View this article via: PubMed Google Scholar
7. Tricot O, Mallat Z, Heymes C, Belmin J, Leseche G, Tedgui A. Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation. 2000;101(21):2450–2453.
   View this article via: PubMed Google Scholar
8. Slager CJ, et al. The role of shear stress in the generation of rupture-prone vulnerable plaques. Nat Clin Pract Cardiovasc Med. 2005;2(8):401–407.
   View this article via: PubMed CrossRef Google Scholar
9. Porat RM, et al. Specific induction of tie1 promoter by disturbed flow in atherosclerosis-prone vascular niches and flow-obstructing pathologies. Circ Res. 2004;94(3):394–401.
   View this article via: PubMed CrossRef Google Scholar
10. Chen-Konak L, et al. Transcriptional and post-translation regulation of the Tie1 receptor by fluid shear stress changes in vascular endothelial cells. FASEB J. 2003;17(14):2121–2123.
    View this article via: PubMed Google Scholar
11. Partanen J, et al. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol. 1992;12(4):1698–1707.
    View this article via: PubMed Google Scholar
12. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J. 1995;14(23):5884–5891.
    View this article via: PubMed Google Scholar
13. Sato TN, et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 1995;376(6535):70–74.
    View this article via: PubMed CrossRef Google Scholar
14. Antonescu CR, et al. KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors. Cancer Res. 2009;69(18):7175–7179.
    View this article via: PubMed CrossRef Google Scholar
15. Kaipainen A, et al. Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res. 1994;54(24):6571–6577.
    View this article via: PubMed Google Scholar
16. Korhonen J, et al. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood. 1992;80(10):2548–2555.
    View this article via: PubMed Google Scholar
17. Shahrara S, Volin MV, Connors MA, Haines GK, Koch AE. Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue. Arthritis Res. 2002;4(3):201–208.
    View this article via: PubMed CrossRef Google Scholar
18. Malik NM, et al. Regulation of the Angiopoietin-Tie ligand-receptor system with a novel splice variant of Tie1 reduces the severity of murine arthritis. Rheumatology (Oxford). 2010;49(10):1828–1839.
    View this article via: CrossRef Google Scholar
19. Chan B, Yuan HT, Ananth Karumanchi S, Sukhatme VP. Receptor tyrosine kinase Tie-1 overexpression in endothelial cells upregulates adhesion molecules. Biochem Biophys Res Commun. 2008;371(3):475–479.
    View this article via: PubMed CrossRef Google Scholar
20. Marron MB, Hughes DP, Edge MD, Forder CL, Brindle NP. Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2. J Biol Chem. 2000;275(50):39741–39746.
    View this article via: PubMed CrossRef Google Scholar
21. Saharinen P, et al. Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J Cell Biol. 2005;169(2):239–243.
    View this article via: PubMed CrossRef Google Scholar
22. Yuan HT, et al. Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival. FASEB J. 2007;21(12):3171–3183.
    View this article via: PubMed CrossRef Google Scholar
23. Saharinen P, et al. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol. 2008;10(5):527–537.
    View this article via: PubMed CrossRef Google Scholar
24. Kim KL, et al. Interaction between Tie receptors modulates angiogenic activity of angiopoietin2 in endothelial progenitor cells. Cardiovasc Res. 2006;72(3):394–402.
    View this article via: PubMed CrossRef Google Scholar
25. Seegar TC, et al. Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands. Mol Cell. 2010;37(5):643–655.
    View this article via: PubMed CrossRef Google Scholar
26. Marron MB, Hughes DP, McCarthy MJ, Beaumont ER, Brindle NP. Tie-1 receptor tyrosine kinase endodomain interaction with SHP2: potential signalling mechanisms and roles in angiogenesis. Adv Exp Med Biol. 2000;476:35–46.
    View this article via: PubMed Google Scholar
27. Taichman DB, Schachtner SK, Li Y, Puri MC, Bernstein A, Scott Baldwin H. A unique pattern of Tie1 expression in the developing murine lung. Exp Lung Res. 2003;29(2):113–122.
    View this article via: PubMed CrossRef Google Scholar
28. Peacock JA. An in vitro study of the onset of turbulence in the sinus of Valsalva. Circ Res. 1990;67(2):448–460.
    View this article via: PubMed Google Scholar
29. Simmons CA, Grant GR, Manduchi E, Davies PF. Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ Res. 2005;96(7):792–799.
    View this article via: PubMed CrossRef Google Scholar
30. Cheng C, et al. Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique. Blood. 2005;106(12):3691–3698.
    View this article via: PubMed CrossRef Google Scholar
31. Cheng C, et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation. 2006;113(23):2744–2753.
    View this article via: PubMed CrossRef Google Scholar
32. Fazio S, et al. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci U S A. 1997;94(9):4647–4652.
    View this article via: PubMed CrossRef Google Scholar
33. Gothert JR, et al. Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood. 2004;104(6):1769–1777.
    View this article via: PubMed CrossRef Google Scholar
34. Reckless J, Metcalfe JC, Grainger DJ. Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice. Circulation. 1997;95(6):1542–1548.
    View this article via: PubMed Google Scholar
35. Marron MB, et al. Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2. J Biol Chem. 2007;282(42):30509–30517.
    View this article via: PubMed CrossRef Google Scholar
36. McCarthy MJ, Burrows R, Bell SC, Christie G, Bell PR, Brindle NP. Potential roles of metalloprotease mediated ectodomain cleavage in signaling by the endothelial receptor tyrosine kinase Tie-1. Lab Invest. 1999;79(7):889–895.
    View this article via: PubMed Google Scholar
37. Kuchan MJ, Frangos JA. Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am J Physiol. 1994;266(3 pt 1):C628–636.
    View this article via: PubMed Google Scholar
38. Lee HJ, Koh GY. Shear stress activates Tie2 receptor tyrosine kinase in human endothelial cells. Biochem Biophys Res Commun. 2003;304(2):399–404.
    View this article via: PubMed CrossRef Google Scholar
39. Suo J, Ferrara DE, Sorescu D, Guldberg RE, Taylor WR, Giddens DP. Hemodynamic shear stresses in mouse aortas: implications for atherogenesis. Arterioscler Thromb Vasc Biol. 2007;27(2):346–351.
    View this article via: PubMed CrossRef Google Scholar
40. Cheng C, et al. Large variations in absolute wall shear stress levels within one species and between species. Atherosclerosis. 2007;195(2):225–235.
    View this article via: PubMed CrossRef Google Scholar
41. Greve JM, et al. Allometric scaling of wall shear stress from mice to humans: quantification using cine phase-contrast MRI and computational fluid dynamics. Am J Physiol Heart Circ Physiol. 2006;291(4):H1700–H1708.
    View this article via: PubMed CrossRef Google Scholar
42. Patan S. TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth. Microvasc Res. 1998;56(1):1–21.
    View this article via: PubMed CrossRef Google Scholar
43. Kontos CD, Cha EH, York JD, Peters KG. The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis. Mol Cell Biol. 2002;22(6):1704–1713.
    View this article via: PubMed CrossRef Google Scholar
44. Eklund L, Olsen BR. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res. 2006;312(5):630–641.
    View this article via: PubMed CrossRef Google Scholar
45. Goel R, et al. Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2008;28(11):1996–2002.
    View this article via: PubMed CrossRef Google Scholar
46. Harry BL, et al. Endothelial cell PECAM-1 promotes atherosclerotic lesions in areas of disturbed flow in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2008;28(11):2003–2008.
    View this article via: PubMed CrossRef Google Scholar
47. Butcher JT, et al. Transcriptional profiles of valvular and vascular endothelial cells reveal phenotypic differences: influence of shear stress. Arterioscler Thromb Vasc Biol. 2006;26(1):69–77.
    View this article via: PubMed CrossRef Google Scholar
48. Jat PS, et al. Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci U S A. 1991;88(12):5096–5100.
    View this article via: PubMed CrossRef Google Scholar
49. Langley RR, Ramirez KM, Tsan RZ, Van Arsdall M, Nilsson MB, Fidler IJ. Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis. Cancer Res. 2003;63(11):2971–2976.
    View this article via: PubMed Google Scholar
50. Lidington EA, Rao RM, Marelli-Berg FM, Jat PS, Haskard DO, Mason JC. Conditional immortalization of growth factor-responsive cardiac endothelial cells from H-2K(b)-tsA58 mice. Am J Physiol Cell Physiol. 2002;282(1):C67–74.
    View this article via: PubMed Google Scholar
51. Whitehead RH, VanEeden PE, Noble MD, Ataliotis P, Jat PS. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc Natl Acad Sci U S A. 1993;90(2):587–591.
    View this article via: PubMed CrossRef Google Scholar
52. Remuzzi A, Dewey CF Jr, Davies PF, Gimbrone MA Jr. Orientation of endothelial cells in shear fields in vitro. Biorheology. 1984;21(4):617–630.
    View this article via: PubMed Google Scholar
53. Noma K, Oyama N, Liao JK. Physiological role of ROCKs in the cardiovascular system. Am J Physiol Cell Physiol. 2006;290(3):C661–C668.
    View this article via: PubMed CrossRef Google Scholar
54. Zhou Q, Liao JK. Rho kinase: an important mediator of atherosclerosis and vascular disease. Curr Pharm Des. 2009;15(27):3108–3115.
    View this article via: PubMed CrossRef Google Scholar
55. Gimbrone MA Jr, et al. Special communicationthe critical role of mechanical forces in blood vessel development, physiology and pathology. J Vasc Surg. 1999;29(6):1104–1151.
    View this article via: PubMed CrossRef Google Scholar
56. Chan B, Sukhatme VP. Suppression of Tie-1 in endothelial cells in vitro induces a change in the genome-wide expression profile reflecting an inflammatory function. FEBS Lett. 2009;583(6):1023–1028.
    View this article via: PubMed CrossRef Google Scholar
57. Ahmed A, et al. Angiopoietin-2 confers Atheroprotection in apoE^–/– mice by inhibiting LDL oxidation via nitric oxide. Circ Res. 2009;104(12):1333–1336.
    View this article via: PubMed CrossRef Google Scholar
58. Qu X, Tompkins K, Batts LE, Puri M, Baldwin S. Abnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice. Development. 2010;137(8):1285–1295.
    View this article via: PubMed CrossRef Google Scholar
59. Babaev VR, et al. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2005;25(8):1647–1653.
    View this article via: PubMed CrossRef Google Scholar